Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing

Filed Under: Pharma Tagged With: , , , , , ,

Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Sumitomo Chemical Pursues Genome Editing for Agricultural Cultivation
Sumitomo Chemical Pursues Genome Editing for Agricultural…
Daicel Targets 2024 for Launch of Centralized Medical Business
Daicel Targets 2024 for Launch of Centralized Medical…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of Oligonucleotides…